|
4-Biphenylacetic acid
|
4-联苯乙酸
|
5728-52-9
|
|
Cinchonine
|
辛可宁
|
118-10-5
|
|
EPZ005687
|
EPZ005687
|
1396772-26-1
|
|
RG2833
|
RG2833(RGFP109)
|
1215493-56-3
|
|
UNC1999
|
UNC1999
|
1431612-23-5
|
|
Sulfacetamide sodium
|
磺胺醋酰钠一水合物
|
6209-17-2
|
|
Tenovin-6Hydrochloride
|
TENOVIN 2
|
1011301-29-3
|
|
BRD4770
|
2-苯甲酰胺基-1-(3-苯丙基)-1H-苯并[D]咪唑-5-羧酸甲酯
|
1374601-40-7
|
|
GSK3235025
|
EPZ015666
|
1616391-65-1
|
|
PT-2385
|
CS-2108
|
1672665-49-4
|
|
KIRA6
|
CS-2625
|
1589527-65-0
|
|
GSK3326595
|
GSK-3326595
|
1616392-22-3
|
|
Selonsertib
|
司隆色替
|
1448428-04-3
|
|
GSK481
|
CS-2186
|
1622849-58-4
|
|
CBL0137Hydrochloride
|
CBL0137盐酸盐
|
1197397-89-9
|
|
MKC-3946
|
1093119-54-0
|
1093119-54-0
|
|
GSK872
|
GSK872
|
1346546-69-7
|
|
LYS-05
|
Lys05
|
1391426-24-6
|
|
FX1
|
CS-2497
|
1426138-42-2
|
|
Aceclofenac
|
醋氯芬酸
|
89796-99-6
|
|
IITZ-01
|
IITZ-01
|
1807988-47-1
|
|
SINAPINALDEHYDE
|
Trans-3,5-二甲氧基-4-羟基肉桂醛
|
4206-58-0
|
|
(S)-3-((S)-2-(2-(2-tert-butylphenylamino)-2-oxoacetamido)propanamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid
|
恩利卡生
|
254750-02-2
|
|
7-hydroxy-4-Methyl-2-oxo-2H-1-Benzopyran-8-carboxaldehyde
|
8-甲酰基-7-羟基-4-甲基香豆素
|
14003-96-4
|
|
3-Cyclopentene-1,2-diol, 5-(4-aMino-1H-iMidazo[4,5-c]pyridin-1-yl)-3-(hydroxyMethyl)-, (Hydrochloride) (1:1), (1S,2R,5R)-
|
3-去氮腺嘌呤A盐酸盐
|
120964-45-6
|
|
Birinapant
|
比瑞那帕
|
1260251-31-7
|
|
TMP195
|
TMP195游离态
|
1314891-22-9
|
|
UNC0642
|
2-(4,4-二氟-1-哌啶基)-6-甲氧基-N-[1-异丙基-4-哌啶基]-7-[3-(1-吡咯烷基)丙氧基]-4-喹唑啉胺
|
1481677-78-4
|
|
5-IODOTUBERCIDIN
|
5-碘代杀结核菌素
|
24386-93-4
|
|
ARV-825
|
CS-2252
|
1818885-28-7
|
|
A-1155463
|
醋酸艾塞那肽
|
1235034-55-5
|
|
CCF642
|
3-(4-甲氧基苯基)-5-[(5-硝基-2-噻吩基)亚甲基]-2-硫代-4-噻唑烷酮
|
346640-08-2
|
|
NSC228155
|
NSC228155
|
113104-25-9
|
|
A2ARAntagonist1
|
443103-97-7
|
443103-97-7
|
|
Tucidinostat (Chidamide)
|
西达本胺
|
1616493-44-7
|
|
1-(3,4-DICHLOROBENZYL)-1H-INDOLE-2,3-DIONE
|
凋亡活化剂2
|
79183-19-0
|
|
Diaveridine
|
敌菌净
|
5355-16-8
|
|
LY-411575
|
(AS)-N-[(1S)-2-[[(7S)-6,7-二氢-5-甲基-6-氧代-5H-二苯并[B,D]氮杂卓-7-基]氨基]-1-甲基-2-氧代乙基]-3,5-二氟-ALPHA-羟基苯乙酰胺
|
209984-57-6
|
|
CID755673
|
2,3,4,5-Tetrahydro-7-hydroxy-1H-benzofuro[2,3-c]azepin-1-one
|
521937-07-5
|
|
UNC0638
|
UNC0638
|
1255580-76-7
|
|
AT-101
|
(R)-棉子酚乙酸
|
866541-93-7
|
|
SRPIN340
|
SRPKINHIBITOR
|
218156-96-8
|
|
STF083010
|
STF 083010
|
307543-71-1
|
|
CPI169
|
化合物CPI169
|
1450655-76-1
|
|
NVP-CGM097
|
CS-1248
|
1313363-54-0
|
|
Citarinostat
|
西他司他
|
1316215-12-9
|
|
ReModelin hydrobroMide
|
4-[2-(2-环戊基亚基肼基)-4-噻唑基]苯甲腈氢溴酸盐
|
1622921-15-6
|
|
SP2509
|
SP2509
|
1423715-09-6
|
|
ABBV-075
|
米维布塞
|
1445993-26-9
|
|
dBET1
|
dBET1
|
1799711-21-9
|
|
WNK463
|
N-(叔丁基)-1-(1-(5-(5-(三氟甲基)-1,3,4-恶二唑-2-基)吡啶-2-基)哌啶-4-基)-1H-咪唑-5-甲酰胺
|
2012607-27-9
|
|
WT-161
|
CS-2547
|
1206731-57-8
|
|
ROC-325
|
ROC-325
|
1859141-26-6
|
|
T-3775440 hydrochloride
|
T-3775440盐酸盐
|
1422535-52-1
|
|
INCB-054329
|
1628607-64-6
|
1628607-64-6
|
|
DC661
|
DC661
|
1872387-43-3
|
|
Flubendazole
|
氟苯咪唑
|
31430-15-6
|
|
Salmeterol xinafoate
|
昔美酸沙美特罗
|
94749-08-3
|
|
Methocarbamol
|
美索巴莫
|
532-03-6
|
|
Nutlin-3a
|
Nutlin 3a
|
675576-98-4
|
|
R788(Fostamatinib disodium)
|
福他替尼二钠盐
|
1025687-58-4
|
|
Xylometazoline hydrochloride
|
盐酸赛洛唑啉
|
1218-35-5
|
|
Tubastatin A hydrochloride
|
TubastatinA盐酸盐
|
1310693-92-5
|
|
Tenovin-6
|
TENOVIN-6
|
1011557-82-6
|
|
Sabutoclax
|
SABUTOCLAX
|
1228108-65-3
|
|
N-(2-(2-(4-chlorophenyl)thiazol-4-yl)ethyl)butyraMide
|
N-[2-[2-(4-氯苯基)-4-噻唑基]乙基]丁酰胺
|
932986-18-0
|
|
SGC-0946
|
SGC0946
|
1561178-17-3
|
|
PND-1186
|
PND1186
|
1061353-68-1
|
|
RG-7388
|
依达奴林
|
1229705-06-9
|
|
TubastatinA
|
TUBASTATIN A
|
1252003-15-8
|
|
Canagliflozin heMihydrate
|
坎格列净半水合物
|
928672-86-0
|
|
MM-102
|
MM-102
|
1417329-24-8
|
|
GSK591
|
GSK591 (EPZ-015866)
|
1616391-87-7
|
|
CPI1205
|
CPDB1215
|
1621862-70-1
|
|
RIPA-56
|
RIPA-56
|
1956370-21-0
|
|
Salubrinal
|
SALUBRINAL
|
405060-95-9
|
|
Tafluprost
|
他氟前列素
|
209860-87-7
|
|
Tamsulosin hydrochloride
|
盐酸坦索罗辛
|
106463-17-6
|
|
Pifithrin-μ
|
苯乙炔基磺酰胺
|
64984-31-2
|
|
Corynoxine
|
柯诺辛
|
6877-32-3
|
|
Tolvaptan
|
托伐普坦
|
150683-30-0
|
|
PK11007
|
PK11007
|
38275-34-2
|
|
SULFAPHENAZOLE
|
磺胺苯吡唑
|
526-08-9
|
|
Menin-MLL inhibitor MI-2
|
MI-2 (Menin-MLL Inhibitor)
|
1271738-62-5
|
|
MI-3
|
MI-3 (Menin-MLL Inhibitor)
|
1271738-59-0
|
|
Nutlin-3b
|
Nutlin-3b
|
675576-97-3
|
|
CarbaMiMidothioic acid, 3-cyanopropyl ester, hydrochloride (1:1)
|
3-氰基丙基异硫脲盐酸盐
|
66592-89-0
|
|
I-BET-762
|
(4S)-6-(4-氯苯基)-N-乙基-8-甲氧基-1-甲基-4H-[1,2,4]三唑并[4,3-A][1,4]苯并二氮杂卓-4-乙酰胺
|
1260907-17-2
|
|
CID-20°C11756
|
CID-2011756
|
638156-11-3
|
|
Pinometostat
|
(2R,3R,4S,5R)-2-(6-氨基-9H-嘌呤-9-基)-5-((((1R,3S)-3-(2-(6-(叔丁基)-1H-苯并[D]咪唑-2-基)乙基)环丁基)(异丙基)氨基)甲基)四氢呋喃-3,4-二醇
|
1380288-87-8
|
|
SGI-1027
|
SGI-1027
|
1020149-73-8
|
|
CPI203
|
CPI-203
|
1446144-04-2
|
|
CPI-360
|
EZH2抑制剂(CPI-360)
|
1802175-06-9
|
|
MI-773
|
SAR 405838
|
1303607-60-4
|
|
PFK-158
|
1G,10G,100G,1KG
|
1462249-75-7
|
|
A366
|
A-366
|
1527503-11-2
|
|
Brigatinib
|
布格替尼
|
1197953-54-0
|
|
PIK-Ⅲ
|
PIK-III
|
1383716-40-2
|
|
OICR9429
|
OICR-9429
|
1801787-56-3
|
|
MX-69
|
MX69
|
1005264-47-0
|
|
YANGONIN
|
甲氧醉椒素
|
500-62-9
|
|
S64315
|
S64315(MIK665)
|
1799631-75-6
|
|
CVT-313
|
CVT 313
|
199986-75-9
|
|
MK-8617
|
MK-8617
|
1187990-87-9
|
|
2-(Hydroxymethyl)-2-(methoxymethyl)-1-azabicyclo[2.2.2]octan-3-one
|
2-(羟甲基)-2-(甲氧基甲基)奎宁-3-酮
|
5291-32-7
|
|
4,5-Dihydro-3-phenyl-5-isoxazoleaceticacid
|
3-苯基-2-异恶唑啉-5-乙酸
|
6501-72-0
|
|
Rebastinib
|
N-[3-叔丁基-1-(喹啉-6-基)-1H-吡唑-5-基]-N'-[2-氟-4-[(2-(甲基氨基甲酰基)吡啶-4-基)氧]苯基]脲
|
1020172-07-9
|
|
RVX-208
|
阿帕他隆
|
1044870-39-4
|
|
EI1
|
6-氰基-N-[(1,2-二氢-4,6-二甲基-2-氧代-3-吡啶基)甲基]-1-(1-乙基丙基)-1H-吲哚-4-甲酰胺
|
1418308-27-6
|
|
NSC319726
|
NSC319726
|
71555-25-4
|
|
GSK2801
|
GSK2801
|
1619994-68-1
|
|
SGC-CBP30
|
SGC-CBP30
|
1613695-14-9
|
|
Bromosporine
|
C17H20N6O4S
|
1619994-69-2
|
|
Crenigacestat
|
CRENIGACESTAT
|
1421438-81-4
|
|
GNE-0877
|
GNE-0877
|
1374828-69-9
|
|
UMI-77
|
UMI-77
|
518303-20-3
|
|
AZD5582
|
AZD 5582
|
1258392-53-8
|
|
PF-06447475
|
PF-06447475
|
1527473-33-1
|
|
GSK2982772
|
GSK2982772
|
1622848-92-3
|
|
HLCL-61 (hydrochloride)
|
HLCL-61盐酸盐
|
1158279-20-9
|
|
CID5721353
|
301356-95-6
|
301356-95-6
|
|
PF-06726304
|
PF-06726304
|
1616287-82-1
|
|
PLX51107
|
化合物PLX51107
|
1627929-55-8
|
|
BI-3812
|
CPD1815
|
2166387-64-8
|
|
SKLB-23bb
|
SKLB-23bb
|
1815580-06-3
|
|
GSK547
|
GSK547
|
2226735-55-1
|
|
2-Ethoxybenzamide
|
2-乙氧基苯甲酰胺
|
938-73-8
|
|
Travoprost
|
曲伏前列素
|
157283-68-6
|
|
Bithionol
|
硫氯酚
|
97-18-7
|
|
Entacapone
|
恩他卡朋
|
130929-57-6
|
|
Tacedinaline
|
他地那兰
|
112522-64-2
|
|
Etretinate
|
依曲替酯
|
54350-48-0
|
|
RG-7112
|
[(4R,5S)-4,5-双(4-氯苯基)-2-[4-(1,1-二甲基乙基)-2-乙氧基苯基]-4,5-二氢-4,5-二甲基-1H-咪唑-1-基][4-[3-(甲磺酰基)丙基]-1-哌嗪基]甲酮
|
939981-39-2
|
|
5,6,7,8-Tetrahydro-2-(4-methylphenyl)-imidazo[2,1-b]benzothiazolehydrobromide
|
环状抑制剂-Α氢溴酸盐
|
511296-88-1
|
|
N1,N4-Di-2-pyridinyl-1,4-benzenedimethanamine
|
N,N'-二-2-吡啶基-1,4-苯二甲胺
|
55778-02-4
|
|
GSK2606414
|
GSK2606414
|
1337531-36-8
|
|
ABT-199
|
维萘妥拉
|
1257044-40-8
|
|
LCL-161
|
LCL161
|
1005342-46-0
|
|
GSK2656157
|
GSK2656157
|
1337532-29-2
|
|
GSK1324726A
|
GSK1324726A (I-BET726)
|
1300031-52-0
|
|
PFI3
|
(2E)-1-(2-羟基苯基)-3-[(1R,4R)-5-(2-吡啶基)-2,5-二氮杂双环[2.2.1]庚-2-基]-2-丙烯-1-酮
|
1819363-80-8
|
|
EDO-S101
|
EDO-S101
|
1236199-60-2
|
|
MI463
|
1628317-18-9
|
1628317-18-9
|
|
CRT0066101Dihydrochloride
|
CS-2578
|
1883545-60-5
|
|
AZD5991
|
AZD5991
|
2143010-83-5
|
|
Ac-DEVD-CHO
|
乙酰基-天冬氨酰-谷氨酰-缬氨酰-天冬氨醛
|
169332-60-9
|
|
BH3I-1
|
BH3I-1
|
300817-68-9
|
|
Bosentan hydrate
|
波生坦一水合物
|
157212-55-0
|
|
Sodium gualenate
|
磺酸钠
|
6223-35-4
|
|
PAC-1
|
PAC1
|
315183-21-2
|
|
KW-2449
|
[4-[2-(1H-吲唑-3-基)乙烯基]苯基]-1-哌嗪基甲酮
|
1000669-72-6
|
|
MG149
|
MG149
|
1243583-85-8
|
|
GSK126
|
GSK126
|
1346574-57-9
|
|
UNC1215
|
UNC1215
|
1415800-43-9
|
|
GSKJ1
|
N-[2-(2-吡啶基)-6-(1,2,4,5-四氢-3H-3-苯并氮杂卓-3-基)-4-嘧啶基]-BETA-丙氨酸
|
1373422-53-7
|
|
PFK15
|
PFK-015
|
4382-63-2
|
|
ISRIB(trans-isomer)
|
ISRIB(TRANS-ISOMER) 抑制剂
|
1597403-47-8
|
|
GNE-9605
|
GNE-9605
|
1536200-31-3
|
|
BAY85-3934
|
MOLIDUSTAT
|
1154028-82-6
|
|
GSK503
|
化合物GSK503
|
1346572-63-1
|
|
ML324
|
ML324
|
1222800-79-4
|
|
CHLOROQUINE
|
氯喹
|
54-05-7
|
|
A-1210477
|
A-1210477
|
1668553-26-1
|
|
Vadadustat
|
伐度司他
|
1000025-07-9
|
|
COTI-2
|
COTI-2
|
1039455-84-9
|
|
S55746
|
化合物S55746
|
1448584-12-0
|
|
RITA
|
5,5'-(2,5-呋喃二基)二-2-噻吩甲醇
|
213261-59-7
|
|
PRIMA-1
|
2,2-双(羟甲基)奎宁环-3-酮
|
5608-24-2
|
|
Ricolinostat
|
ACY1215
|
1316214-52-4
|
|
Tazemetostat
|
EPZ-6438
|
1403254-99-8
|
|
TMP269
|
TMP269
|
1314890-29-3
|
|
YH239-EE
|
YH239-EE,YH239乙酯
|
1364488-67-4
|
|
Defactinib
|
地法替尼
|
1073154-85-4
|
|
SBI-0206965
|
SBI0206965; SBI-0206965; SBI 0206965.
|
1884220-36-3
|
|
PFI-2 (hydrochloride)
|
PFI-2盐酸盐
|
1627607-87-7
|
|
A-1331852
|
A-1331852
|
1430844-80-6
|
|
MI136
|
MI-136;HY-19319 (MI 136; MI136);
|
1628316-74-4
|
|
I-BRD9
|
GSK602
|
1714146-59-4
|
|
S63845
|
S63845
|
1799633-27-4
|
|
Autophinib
|
6-CHLORO-N-(5-METHYL-1H-PYRAZOL-3-YL)-2-(4-NITROPHENOXY)PYRIMIDIN-4-AMINE
|
1644443-47-9
|
|
GSK3179106
|
GSK3179106
|
1627856-64-7
|
|
lucanthone
|
硫坎酮
|
479-50-5
|
|
ML-7Hydrochloride
|
1-(5-碘萘-1-磺酰基)-1H-六氢-1,4-二氮杂卓盐酸盐
|
110448-33-4
|
|
Cambinol
|
SIRT1/2 INHIBITOR IV
|
14513-15-6
|
|
SAL-003
|
(2E)-3-苯基-N-[2,2,2-三氯-1-[[[(4-氯苯基)氨基]硫代甲酰基]氨基]乙基]-2-丙烯酰胺
|
1164470-53-4
|
|
AZD4547
|
AZD-4547
|
1035270-39-3
|
|
(R) -ginsenoside Rh1
|
(20R)人参皂苷Rh1
|
80952-71-2
|
|
SMER28
|
SMER28
|
307538-42-7
|
|
NSC348884
|
N1,N1,N2,N2-四[(6-甲基-1H-苯并咪唑-2-基)甲基]-1,2-乙二胺
|
81624-55-7
|
|
EPZ004777
|
EPZ004777
|
1338466-77-5
|
|
AT406
|
AT-406
|
1071992-99-8
|
|
TOFOGLIFLOZIN
|
托格列净
|
1201913-82-7
|
|
MarinopyrroleA
|
(±)-MARINOPYRROLE A
|
1227962-62-0
|
|
UNC669
|
UNC669
|
1314241-44-5
|
|
UNC0379
|
UNC0379
|
1620401-82-2
|
|
CREBinhibitor
|
1433286-70-4
|
1433286-70-4
|
|
Siremadlin
|
思瑞德林
|
1448867-41-1
|
|
HA15
|
HA-15
|
1609402-14-3
|
|
LYN-1604
|
蓝木定制的新产品
|
2088939-99-3
|
|
ISOVALERAMIDE
|
异戊酰胺
|
541-46-8
|